Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 120

1.

Prospective study on association between plasma amyloid beta-42 and atherosclerotic risk factors.

Blasko I, Kemmler G, Jungwirth S, Wichart I, Weissgram S, Jellinger K, Tragl KH, Fischer P.

J Neural Transm. 2011 May;118(5):663-72. doi: 10.1007/s00702-011-0599-4. Epub 2011 Feb 23.

PMID:
21344239
[PubMed - indexed for MEDLINE]
2.

Conversion from cognitive health to mild cognitive impairment and Alzheimer's disease: prediction by plasma amyloid beta 42, medial temporal lobe atrophy and homocysteine.

Blasko I, Jellinger K, Kemmler G, Krampla W, Jungwirth S, Wichart I, Tragl KH, Fischer P.

Neurobiol Aging. 2008 Jan;29(1):1-11. Epub 2006 Oct 19.

PMID:
17055615
[PubMed - indexed for MEDLINE]
3.

Association of low plasma Abeta42/Abeta40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease.

Graff-Radford NR, Crook JE, Lucas J, Boeve BF, Knopman DS, Ivnik RJ, Smith GE, Younkin LH, Petersen RC, Younkin SG.

Arch Neurol. 2007 Mar;64(3):354-62. Erratum in: Arch Neurol. 2007 Sep;64(9):1246.

PMID:
17353377
[PubMed - indexed for MEDLINE]
4.

The relationship of plasma Aβ levels to dementia in aging individuals with mild cognitive impairment.

Fei M, Jianghua W, Rujuan M, Wei Z, Qian W.

J Neurol Sci. 2011 Jun 15;305(1-2):92-6. doi: 10.1016/j.jns.2011.03.005. Epub 2011 Mar 26.

PMID:
21440911
[PubMed - indexed for MEDLINE]
5.

Effects of medications on plasma amyloid beta (Abeta) 42: longitudinal data from the VITA cohort.

Blasko I, Jungwirth S, Jellinger K, Kemmler G, Krampla W, Weissgram S, Wichart I, Tragl KH, Hinterhuber H, Fischer P.

J Psychiatr Res. 2008 Sep;42(11):946-55. Epub 2007 Dec 21.

PMID:
18155247
[PubMed - indexed for MEDLINE]
6.

Plasma amyloid beta-42 independently predicts both late-onset depression and Alzheimer disease.

Blasko I, Kemmler G, Jungwirth S, Wichart I, Krampla W, Weissgram S, Jellinger K, Tragl KH, Fischer P.

Am J Geriatr Psychiatry. 2010 Nov;18(11):973-82. doi: 10.1097/JGP.0b013e3181df48be.

PMID:
20808106
[PubMed - indexed for MEDLINE]
7.

Prediction of Alzheimer's disease using the CSF Abeta42/Abeta40 ratio in patients with mild cognitive impairment.

Hansson O, Zetterberg H, Buchhave P, Andreasson U, Londos E, Minthon L, Blennow K.

Dement Geriatr Cogn Disord. 2007;23(5):316-20. Epub 2007 Mar 19.

PMID:
17374949
[PubMed - indexed for MEDLINE]
8.

Cystatin C levels are positively correlated with both Abeta42 and tau levels in cerebrospinal fluid in persons with Alzheimer's disease, mild cognitive impairment, and healthy controls.

Sundelöf J, Sundström J, Hansson O, Eriksdotter-Jönhagen M, Giedraitis V, Larsson A, Degerman-Gunnarsson M, Ingelsson M, Minthon L, Blennow K, Kilander L, Basun H, Lannfelt L.

J Alzheimers Dis. 2010;21(2):471-8. doi: 10.3233/JAD-2010-091594.

PMID:
20555147
[PubMed - indexed for MEDLINE]
9.

Cholesterol, copper and Abeta in controls, MCI, AD and the AD cholesterol-lowering treatment trial (ADCLT).

Sparks DL, Petanceska S, Sabbagh M, Connor D, Soares H, Adler C, Lopez J, Ziolkowski C, Lochhead J, Browne P.

Curr Alzheimer Res. 2005 Dec;2(5):527-39.

PMID:
16375656
[PubMed - indexed for MEDLINE]
10.

Evaluation of plasma Abeta(40) and Abeta(42) as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment.

Hansson O, Zetterberg H, Vanmechelen E, Vanderstichele H, Andreasson U, Londos E, Wallin A, Minthon L, Blennow K.

Neurobiol Aging. 2010 Mar;31(3):357-67. doi: 10.1016/j.neurobiolaging.2008.03.027. Epub 2008 May 19.

PMID:
18486992
[PubMed - indexed for MEDLINE]
11.

Plasma beta-amyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy.

Gurol ME, Irizarry MC, Smith EE, Raju S, Diaz-Arrastia R, Bottiglieri T, Rosand J, Growdon JH, Greenberg SM.

Neurology. 2006 Jan 10;66(1):23-9.

PMID:
16401840
[PubMed - indexed for MEDLINE]
12.

Plasma Abeta42 and Abeta40 as markers of cognitive change in follow-up: a prospective, longitudinal, population-based cohort study.

Seppälä TT, Herukka SK, Hänninen T, Tervo S, Hallikainen M, Soininen H, Pirttilä T.

J Neurol Neurosurg Psychiatry. 2010 Oct;81(10):1123-7. doi: 10.1136/jnnp.2010.205757. Epub 2010 May 16.

PMID:
20478847
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Serum Abeta levels as predictors of conversion to mild cognitive impairment/Alzheimer disease in an ADAPT subcohort.

Abdullah L, Luis C, Paris D, Mouzon B, Ait-Ghezala G, Keegan AP, Wang D, Crawford F, Mullan M.

Mol Med. 2009 Nov-Dec;15(11-12):432-7. doi: 10.2119/molmed.2009.00083. Epub 2009 Aug 18.

PMID:
19707525
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Evaluation of plasma Aβ as predictor of Alzheimer's disease in older individuals without dementia: a population-based study.

Hansson O, Stomrud E, Vanmechelen E, Östling S, Gustafson DR, Zetterberg H, Blennow K, Skoog I.

J Alzheimers Dis. 2012;28(1):231-8. doi: 10.3233/JAD-2011-111418.

PMID:
21955816
[PubMed - indexed for MEDLINE]
15.

Amyloid-β peptides in plasma and cognitive decline after 1 year follow-up in Alzheimer's disease patients.

Laske C, Sopova K, Gkotsis C, Eschweiler GW, Straten G, Gawaz M, Leyhe T, Stellos K.

J Alzheimers Dis. 2010;21(4):1263-9.

PMID:
21504122
[PubMed - indexed for MEDLINE]
16.

Depression is associated with low plasma Abeta42 independently of cardiovascular disease in the homebound elderly.

Qiu WQ, Sun X, Selkoe DJ, Mwamburi DM, Huang T, Bhadela R, Bergethon P, Scott TM, Summergrad P, Wang L, Rosenberg I, Folstein M.

Int J Geriatr Psychiatry. 2007 Jun;22(6):536-42.

PMID:
17096467
[PubMed - indexed for MEDLINE]
17.

Evolution of Abeta42 and Abeta40 levels and Abeta42/Abeta40 ratio in plasma during progression of Alzheimer's disease: a multicenter assessment.

Blennow K, De Meyer G, Hansson O, Minthon L, Wallin A, Zetterberg H, Lewczuk P, Vanderstichele H, Vanmechelen E, Kornhuber J, Wiltfang J; KND-Study Group, Heuser I, Maier W, Luckhaus C, Rüther E, Hüll M, Jahn H, Gertz HJ, Frölich L, Hampel H, Pernetzki R.

J Nutr Health Aging. 2009 Mar;13(3):205-8.

PMID:
19262954
[PubMed - indexed for MEDLINE]
18.

Decreased serum lipids in patients with probable Alzheimer's disease.

Lepara O, Valjevac A, Alajbegović A, Zaćiragić A, Nakas-Ićindić E.

Bosn J Basic Med Sci. 2009 Aug;9(3):215-20.

PMID:
19754476
[PubMed - indexed for MEDLINE]
19.

Change in plasma Aß peptides and onset of dementia in adults with Down syndrome.

Schupf N, Zigman WB, Tang MX, Pang D, Mayeux R, Mehta P, Silverman W.

Neurology. 2010 Nov 2;75(18):1639-44. doi: 10.1212/WNL.0b013e3181fb448b.

PMID:
21041786
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Plasma levels of amyloid beta-protein 42 are increased in women with mild cognitive impairment.

Assini A, Cammarata S, Vitali A, Colucci M, Giliberto L, Borghi R, Inglese ML, Volpe S, Ratto S, Dagna-Bricarelli F, Baldo C, Argusti A, Odetti P, Piccini A, Tabaton M.

Neurology. 2004 Sep 14;63(5):828-31.

PMID:
15365131
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk